A new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trial.
第一作者:
C,von Arx
第一单位:
Department of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples. Electronic address: claudia.vonarx@istitutotumori.na.it.
作者:
主题词
人类(Humans);男(雄)性(Male);女(雌)性(Female);中年人(Middle Aged);癌, 神经内分泌(Carcinoma, Neuroendocrine);老年人(Aged);成年人(Adult);抗肿瘤药, 烷基化(Antineoplastic Agents, Alkylating);用药计划表(Drug Administration Schedule);肺肿瘤(Lung Neoplasms)
DOI
10.1016/j.esmoop.2024.103003
PMID
38615472
发布时间
2024-07-17
- 浏览0
ESMO open
2024年9卷5期
103003页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



